The Increasing Importance of GLP1–Based Therapies for Personalized Obesity Management

CoChairs, Domenica M. Rubino, MD, and Donna H. Ryan, MD, FTOS, discuss the role of weightloss medications for longterm obesity management in this CME activity titled “Gut Feeling: The Increasing Importance of GLP1–Based Therapies for Personalized Obesity Management.” For the full presentation, downloadable Practice Aids, slides, and complete CME information, and to apply for credit, please visit us at PeerView.com/WBN865. CME credit will be available until December 8, 2022.